Craneware plc

("Craneware" or the "Company" or the "Group")

Purchase of Shares by Director and Total Voting Rights

28 April 2025 - Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 24 April 2025, Will Whitehorn, Chair of the Company, purchased 1,911 Ordinary Shares of 1p each in the capital of the Company at a price of 1,584 pence per Ordinary Share.

Following the purchase of Ordinary Shares, Mr. Whitehorn holds 6,500 Ordinary Shares in the capital of the Company, representing 0.018% of the Company's issued share capital (excluding Ordinary Shares held in treasury).

Total Voting Rights

In the period since 1 April 2025 the Company has transferred a total of 1,118 Ordinary Shares previously held in treasury to satisfy the exercise of share options by employees. As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 132,367 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,409,802.This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:  

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                             William Whitehorn

2.   Reason for the notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

i. Aggregated volume            -

ii. Price(s)                              -

For further information, please contact:

About Craneware

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management. 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

Learn more at www.thecranewaregroup.com